Sign Up
OverviewAPI
The global immunoglobulin market is forecasted to grow to $25.6 billion by 2032, driven by factors like increased adoption, rising immunodeficiency diseases, and a growing elderly population. Major players include CSL Limited, Takeda Pharmaceutical, and Pfizer Inc. Innovations in plasma protein therapeutics by companies like Prothya Biosolutions and Grifols S.A. are propelling market expansion, particularly in North America and the Asia-Pacific region. The introduction of products like Omniplasma is enhancing safety measures and catering to customer needs.

Ask a question